Open letter
12 April 2012
To:
Ms. M Hela, Registrar of Medicines. By e-mail
Professor PFK Eagles, Medicines Control Council, Chairperson. By e-mail
Dr. NE Khomo, Medicines Control Council, Vice-Chair. By e-mail
Ms. P Nkambule, MCC Clinical Evaluation & Trials, Clinical Trials Committee. By e-mail
Dr S Munbodh, MCC Clinical Evaluation & Trials, Section 21. By e-mail
CC:
The Hon. Dr. Aaron Motsoaledi, Minister Of Health. By fax
Regarding: Compassionate use of bedaquiline for drug-resistant tuberculosis in South Africa
Dear Registrar Hela, Professor Eagles, Dr. Khomo, Ms. Nkambule, Dr. Munbodh and Honourable Minister Motsoaledi
South Africa has a serious epidemic of drug resistant tuberculosis. Every year approximately 10...
30 June 2011
India protest march
30 May 2011
Dear:
British High Commissioner to South Africa, Swaziland and Lesotho, Dr. Nicola Brewer;
Ambassador of France to South Africa, Mr. Jacques Lapouge;
Ambassador of the Federal Republic of Germany to South Africa, Mr. Dieter W. Haller;
Ambassador of the Swiss Confederation to South Africa, Mr. Rudolf Bärfuss;
Attaché: Health Sector, Delegation of the European Union to South Africa, Ms. Esther Bouma;
Re: The UN High Level Meeting on HIV & AIDS and Universal Access to HIV Treatment
We write to you today from Médecins Sans Frontières/Doctors Without Borders (MSF), the Treatment Action Campaign, SECTION27 incorporating the AIDS Law Project, and the AIDS and Rights Alliance for Southern Africa, gravely concerned...
20 May 2011
Dear President Jacob Zuma, Deputy President Kgalema Motlanthe, Minister of Health Aaron Motsoaledi, Director General for Health Precious Matsotso, and the South African National AIDS Council.
We write to you today as representatives from the Treatment Action Campaign, SECTION27 incorporating the AIDS Law Project, Médecins Sans Frontières /Doctors Without Borders (MSF), World AIDS Campaign, and the AIDS and Rights Alliance of Southern Africa.
Considering the upcoming United Nations General Assembly High Level Meeting on HIV/AIDS, taking place from 8-10 June 2011 in New York, we are writing to share our perspectives on the urgent need for Member States to set ambitious, measurable treatment targets, coupled with enabling...
19 May 2011
This letter was sent to Heads of State or Governments of Member States of the European Union, to Presidents of European Institutions, and to the offices of the UN High Commissioner for Refugees, the UN High Commissioner for Human Rights, and the International Organisation for Migration. It was subsequently published in national newspapers in countries throughout the European Union.
In the name of protecting civilians in Libya, the leaders of several Member States of the European Union have committed their countries to a war against the forces of Muammar Gaddafi. The conflict has already displaced more than 750,000 civilians, who have fled violence in their country.
Despite difficult conditions, Tunisia and Egypt...
25 April 2011
Mr. William C. Weldon
CEO and Chairman of the Board
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
USA
New York, April 20, 2011
Dear Mr. Weldon,
Doctors Without Borders/Médecins Sans Frontières (MSF) wrote to you in the fall of 2009 and 2010 urging Tibotec/Johnson & Johnson (J&J) to license its HIV/AIDS patents to the Medicines Patent Pool established by UNITAID.
As you are aware the Medicines Patent Pool has started negotiations with companies and has already received widespread support from governments and international organizations, as well as its first license from the U.S. National Institutes of Health (NIH) for several patents relating to J&J’s HIV...
